Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism/Experiment 8

From BugSigDB


Reviewed Marked as Reviewed by Atrayees on 2023-7-13

Curated date: 2021/09/30

Curator: Fcuevas3

Revision editor(s): Fcuevas3, WikiWorks, Atrayees

Subjects

Location of subjects
Italy
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Parkinson's disease IDIOPATHIC PARKINSON DIS,Idiopathic Parkinson Disease,Idiopathic Parkinson's Disease,IDIOPATHIC PARKINSONS DIS,Idiopathic PD,LEWY BODY PARKINSON DIS,Lewy Body Parkinson Disease,Lewy Body Parkinson's Disease,Paralysis agitans,paralysis agitans,PARKINSON DIS,PARKINSON DIS IDIOPATHIC,Parkinson disease,Parkinson Disease, Idiopathic,Parkinson syndrome,Parkinson's,Parkinson's disease,Parkinson's disease (disorder),Parkinson's disease NOS,Parkinson's disease NOS (disorder),Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinson's syndrome,Parkinsonian disorder,Parkinsonism, Primary,Parkinsons,PARKINSONS DIS,PARKINSONS DIS IDIOPATHIC,PARKINSONS DIS LEWY BODY,Parkinsons disease,Primary Parkinsonism,parkinson's disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls without any form of Parkinson's Disease
Group 1 name Corresponds to the case (exposed) group for case-control studies
patients with advanced stage Parkinson's
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with advanced stage Parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)
Group 0 sample size Number of subjects in the control (unexposed) group
113
Group 1 sample size Number of subjects in the case (exposed) group
44

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Negative Binomial Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
.05
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, geographic area
Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
age, alcohol drinking, breast feeding, sex, smoking status, constipation, Confounders controlled for: "use of catechol-O-methyltransferase inhibitors" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.use of catechol-O-methyltransferase inhibitors, Confounders controlled for: "genetic status (recessive)" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.genetic status (recessive), Confounders controlled for: "protein intake" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.protein intake, Confounders controlled for: "animal vegetal protein ratio" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.animal vegetal protein ratio, Confounders controlled for: "fibers intake" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.fibers intake, Confounders controlled for: "insoluble-soluble fiber ratio" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.insoluble-soluble fiber ratio, Confounders controlled for: "water intake [mL/day]" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.water intake [mL/day], Confounders controlled for: "coffee intake" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.coffee intake, Confounders controlled for: "use of protein pump inhibitors" is not in the list (abnormal glucose tolerance, acetaldehyde, acute graft vs. host disease, acute lymphoblastic leukemia, acute myeloid leukemia, adenoma, age, AIDS, alcohol consumption measurement, alcohol drinking, ...) of allowed values.use of protein pump inhibitors


Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-7-13

Curated date: 2021/09/30

Curator: Fcuevas3

Revision editor(s): Fcuevas3, Atrayees

Source: Supplementary table 4, Signature 1 is for increased taxa abundance among those with advanced Parkinson's

Description: Analysis of relative taxa abundance in different groups of Parkinson’s disease patients

Abundance in Group 1: increased abundance in patients with advanced stage Parkinson's

NCBI Quality ControlLinks
Akkermansia
Enterobacteriaceae
Pseudomonadota
Verrucomicrobiota
Verrucomicrobiaceae
Escherichia
Streptococcaceae
Lactobacillus
Lactobacillaceae
Christensenellaceae
Parabacteroides
Actinomycetota
Bifidobacterium
Porphyromonadaceae
Bifidobacteriaceae
Coriobacteriaceae

Revision editor(s): Fcuevas3, Atrayees

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-7-13

Curated date: 2021/09/30

Curator: Fcuevas3

Revision editor(s): Fcuevas3, Atrayees

Source: Supplementary table 4, Signature 2 is for decreased taxa abundance among those with advanced Parkinson's

Description: Analysis of relative taxa abundance in different groups of Parkinson’s disease patients

Abundance in Group 1: decreased abundance in patients with advanced stage Parkinson's

NCBI Quality ControlLinks
Bacillota
Lachnospiraceae
Faecalibacterium
Roseburia
Oscillospiraceae

Revision editor(s): Fcuevas3, Atrayees